Literature DB >> 16633136

Recommendations for probiotic use.

Martin H Floch1, Karen K Madsen, David J A Jenkins, Stefano Guandalini, Jeffery A Katz, Andrew Onderdonk, W Allan Walker, Richard N Fedorak, Michael Camilleri.   

Abstract

Probiotics are live microbial organisms that are administrated as supplements or in foods to benefit the host. It is the recommendation that they may be helpful in the prevention and treatment of acute diarrhea in adults and children, the prevention of antibiotic-associated diarrhea in adults and children, and the maintenance of remission and prevention of pouchitis. Although early results indicate that probiotics may also be useful in immunologic modulation to prevent atopy, treatment of radiation intestinal disease, vaginosis, ulcerative colitis, and the irritable bowel syndrome, the studies available are not sufficient to say they are definitely helpful. Even fewer data are available to recommend probiotics for the treatment of H pylori and Crohn disease and for the prevention of cardiovascular risk factors or other degenerative diseases. Clearly, larger and better-designed studies of probiotics are necessary, including comparative and dose-ranging trials.

Entities:  

Mesh:

Year:  2006        PMID: 16633136     DOI: 10.1097/00004836-200603000-00022

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  16 in total

Review 1.  Microbial host interactions in IBD: implications for pathogenesis and therapy.

Authors:  R Balfour Sartor; Marcus Muehlbauer
Journal:  Curr Gastroenterol Rep       Date:  2007-12

2.  The emerging therapeutic role of probiotics in inflammatory bowel disease.

Authors:  Matthew Chandler; Eric Wollins; Anastasia Toles; Marie Borum; David B Doman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-09

3.  Probiotics as therapy in gastroenterology: a study of physician opinions and recommendations.

Authors:  Michael D Williams; Christina Y Ha; Matthew A Ciorba
Journal:  J Clin Gastroenterol       Date:  2010-10       Impact factor: 3.062

4.  VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-κB pathway in rat model of DSS-induced colitis.

Authors:  Cong Dai; Chang-Qing Zheng; Fan-Ji Meng; Zheng Zhou; Li-Xuan Sang; Min Jiang
Journal:  Mol Cell Biochem       Date:  2012-10-23       Impact factor: 3.396

5.  Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome.

Authors:  Dong Hyun Sinn; Ji Hyun Song; Hoi Jin Kim; Jun Haeng Lee; Hee Jung Son; Dong Kyung Chang; Young-Ho Kim; Jae J Kim; Jong Chul Rhee; Poong-Lyul Rhee
Journal:  Dig Dis Sci       Date:  2008-02-15       Impact factor: 3.199

Review 6.  Probiotic therapy in radiation-induced intestinal injury and repair.

Authors:  Matthew A Ciorba; William F Stenson
Journal:  Ann N Y Acad Sci       Date:  2009-05       Impact factor: 5.691

Review 7.  Probiotics as adjunctive therapy for preventing Clostridium difficile infection - What are we waiting for?

Authors:  Jennifer K Spinler; Caná L Ross; Tor C Savidge
Journal:  Anaerobe       Date:  2016-05-13       Impact factor: 3.331

Review 8.  A gastrointestinal anti-infectious biotherapeutic agent: the heat-treated Lactobacillus LB.

Authors:  Vanessa Liévin-Le Moal
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

9.  A new animal model of postsurgical bowel inflammation and fibrosis: the effect of commensal microflora.

Authors:  R J Rigby; M R Hunt; B P Scull; J G Simmons; K E Speck; M A Helmrath; P K Lund
Journal:  Gut       Date:  2009-04-26       Impact factor: 23.059

10.  Dietary and socio-economic factors in relation to Helicobacter pylori re-infection.

Authors:  Mirosław Jarosz; Ewa Rychlik; Magdalena Siuba; Wioleta Respondek; Małgorzata Ryzko-Skiba; Iwona Sajór; Sylwia Gugała; Tomasz Błazejczyk; Janusz Ciok
Journal:  World J Gastroenterol       Date:  2009-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.